Walmarts revelation last October that it was seeing a slight pullback in spend from customers on GLP-1 weight loss drugs prompted a flurry of headlines about Ozempics impact on Big Foods bottom line (although in Walmarts case, the impact is balanced by profits made from selling these drugs at its pharmacies)
At 12 months, 63.2% of members maintained or continued to lose weight
La evidencia comparativa directa es limitada, especialmente fuera de los ensayos clnicos controlados
Blood glucose levels provide immediate feedback, and the risks of poor control are well understood
Now, even as supply stabilizes and FDA shortage designations are lifted, compounded versions remain active in the market, raising critical questions around regulatory oversight, market sustainability, and long-term implications for branded manufacturers